Boditech Med Inc. (KOSDAQ: 206640)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,300
-270 (-1.63%)
Dec 20, 2024, 9:00 AM KST

Boditech Med Company Description

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally.

The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with high-throughput; Hemochroma PLUS, a handheld device that can run tests for anemia; portable analyzers ichroma M3 and ichroma M2; and NuActor, an automated nucleic acid extraction system.

It also provides compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10; cardiac reagents; cancer reagents; COVID-19 reagents; diagnostic reagents; reagents for hormones, infections, autoimmune, organ functions, molecular diagnostics, therapeutic drug monitoring, and other test items.

In addition, the company offers Ichroma TRIAS, ultra-high sensitivity respiratory disease diagnostic equipment; ALFIAS-3, a diagnostic equipment; and SyncNeb.

Boditech Med Inc. was founded in 1998 and is headquartered in Chuncheon-si, South Korea.

Boditech Med Inc.
Country South Korea
Founded 1998
Industry In Vitro and In Vivo Diagnostic Substances
Employees 491

Contact Details

Address:
43, Geodudanji 1-gil
Chuncheon-si, 24398
South Korea
Phone 82 3 3243 1400
Website boditech.co.kr

Stock Details

Ticker Symbol 206640
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 2835